Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications
| Brand name | ACAMPROSATE CALCIUM |
| Generic name | ACAMPROSATE CALCIUM ENTERIC-COATED |
| Active ingredient(s) | ACAMPROSATE CALCIUM |
| Distributed by / for | Mylan Pharmaceuticals Inc., Morgantown, WV 266505 |
| NDC | 0378-6333-80 |
| Full product label | Acamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx only, Mylan Pharmaceuticals Inc., Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 266505, NDC 0378-6333-80. |
| Recalling firm | Mylan Pharmaceuticals Inc |
| Distribution | US Nationwide. |
| Recall initiated | 2026-07-24 |
| Report date | 2026-08-26 |
| Recall completed | — |
| Recall number | D-0774-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Morgantown WV United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗